Baricitinib

Baricitinib · Selective JAK1/JAK2 inhibitor

Rheumatoid arthritis, atopic dermatitis, alopecia areata in patients with inadequate TNF inhibitor response

2mg tablets Once daily oral Insurance Category B

Therapeutic Areas

Anti-Inflammatory

Marketed Products

Baricitinib

Modality

Baricitinib

Core Products

Adalimumab · Fully human anti-TNF-α monoclonal antibody

Tofacitinib · JAK1/JAK3 inhibitor

Creating a Healthier Future Together

Explore our innovative products and pipeline, and see how Poseidon brings hope to patients worldwide